Pioglitazone: side effect and safety profile

Bone metabolism in type 2 diabetes and role of thiazolidinediones

(2011) Peter Vestergaard   Current Opinion in Endocrinology Diabetes and Obesity

Thiazolidinedione use and the risk of fractures

(2009) K. A. Toulis et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years

(2009) Loren D. Grossman et al.   CLINICAL THERAPEUTICS

Standards of Medical Care in Diabetes--2009

(2009)   DIABETES CARE

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes

(2009) John Dormandy et al.   DRUG SAFETY

Liver Safety in Patients with Type 2 Diabetes Treated with Pioglitazone

(2009) Keith G. Tolman et al.   DRUG SAFETY

Thiazolidinediones: Antidiabetic agents with effects on bone

(2009) Françoise Debiais   JOINT BONE SPINE

Review article: Importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptake

(2009) USHA PANCHAPAKESAN et al.   NEPHROLOGY

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

(2008) Y. K. Loke et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

(2008) Naga P. Chalasani et al.   Contemporary Clinical Trials

Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)

(2008) S. E. Kahn et al.   DIABETES CARE

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

(2008) Guruprasad P. Aithal et al.   GASTROENTEROLOGY